Attendee search 

IMC – International Medical Cannabis, one of the 8 government licensed cannabis growers in Israel. Our operation is on an Industrial scale, in compliance with strict Israeli cannabis regulations, assuring security, quality and GAP certification.

IMC is continuing to maintain a leadership position in the Israeli medical cannabis sector and has made great strides towards entering the EU market.

Globally, the expertise and tremendous intellectual property developed within has positioned IMC as world leaders and experts in medical cannabis. This is a strategic advantage that sets us apart from licensed cannabis producers around the globe.

Pharmaseed is a GLP-certified preclinical CRO specialized in preclinical and translational studies in several indications: oncology, CNS, pain & inflammation, cardiovascular diseases, cell therapy and a unique BSL-2 unit for infectious diseases. Pharmaseed is the only preclinical CRO in Israel to hold the permit for Cannabis handling and research. Pharmaseed has all the necessary tools and expertise for preclinical, IND-enabling development of novel therapeutics compounds with specific expertise in med-cannabis. This includes safety and efficacy evaluations in a variety of animal models, and corresponding in-vitro/ex-vivo models.